Adapting to a change in medication will often interrupt a patients weight-loss trajectory, she said, and the trial-and-error could create a lot of waste for medications that were in shortage not long ago
In fact, a Anti-obesity medications like Wegovy should not be used for short-term weight loss, but rather long-term treatment of obesity, which is a chronic disease requiring lifelong intervention, says Dr
Its worth noting that a GLP1 pill (Rybelsus) containing a much lower dose of semaglutide the same active ingredient as Wegovy has been approved by the FDA since 2019 to treat type 2 diabetes
however, individual prescribers and pharmacies are
This triple-action design distinguishes it from other drugs in its class, including semaglutide and tirzepatide, which do not hit all three pathways
In a sense, its the original naked dress